MedWatch

Bavarian Nordic's spending on factory expansion exceeds USD 150m

Past years' expansion of Bavarian Nordic's Danish factory has resulted in expenses "north of USD 151.6m", the firm's COO tells Danish media Børsen.

Photo: Bavarian Nordic / PR

During the past few years, Bavarian Nordic has been expanding its factory located on Zealand, Denmark. The efforts will double the firm's production area next year compared to 2018, Chief Operating Officer at Bavarian Nordic Henrik Birk tells Danish business daily Børsen.

"The expansion increases our total production capacity, enabling us to produce several different vaccines at the same time. The expansion's latest investment in construction and equipment is north of DKK 1bn (USD 151.6m)," he reports.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Britt Meelby Jensen wants to rebuild trust in Ambu

After a turbulent time for Ambu under Juan Jose Gonzalez’s reign, new chief executive appointee Britt Meelby Jensen aims to rebuild the trust in the medtech firm, which has downgraded its expectations seven times over the past three years.

Outgoing Ambu CEO commends colleagues

”A true privilege,” says Juan Jose Gonzalez, describing his time as CEO at Ambu, which came to an end with Thursday’s announcement that Britt Meelby Jensen would take over the role.

Further reading

Related articles

Latest news

See all jobs